Eyal Emmanuel

Chairman, CRISPRIL Consortium, Evogene Ltd.

Dr. Eyal Emmanuel serves as Evogene’s CSO since February 2019. Dr. Emmanuel rejoined Evogene as VP of Corporate Strategy in September 2018, previously held several R&D positions in the Company from May 2006 through October 2017, including Executive R&D Crop Protection and Chief Science Officer. Dr. Emmanuel holds a Ph.D. from the Weizmann Institute of Science and an MBA from the College of Management. Dr. Eyal Emmanuel served from October 2017 to September 2018 as the CTO of the AgriInnovation fund and SVP Ideation at Yissum, the Tech Transfer Office of the Hebrew University.

Suscribirse a las actualizaciones

Una actualización semanal de lo que hay en la Agenda Global

© 2022 World Economic Forum

Política de privacidad y normas de uso